Key Takeaways
- Strong revenue, compressed margins: Revenue jumped 38.9% QoQ to ₹278.3 cr on broad volume growth, but EBITDA margin contracted 388 bps QoQ to 13.6% as costs rose faster than realizations.
- Subsidy receivables are shrinking: The outstanding subsidy balance fell from ₹115 cr to ₹98 cr during the quarter, easing a persistent working-capital overhang.
- A multi-year capacity build is underway: Management laid out a slate of projects across Maharashtra and Madhya Pradesh, with the first phosphoric acid line due in 2QFY26 and the relocated Maharashtra complex targeted for October 2026.
- The balance sheet has already de-risked: FY2024 saw debt fall to ₹289.6 cr, debt-equity improve to 0.83, and operating cash flow swing from negative ₹70 cr to positive ₹149 cr, though debtor days stretched to 83.
- What to watch next quarter: Whether the margin compression stabilizes as new capacity begins contributing, and any update on the timeline for the Maharashtra plant relocation.
Revenue & Volume Performance
- Broad-based volume growth: Both SSP and NPK sales volumes grew during the quarter, outpacing industry growth rates and driving the 38.9% sequential revenue increase.
- PAT held up despite margin hit: Profit after tax rose 20.5% QoQ to ₹13.8 cr, helped by a 24.4% sequential drop in finance costs that partially offset the operating margin compression.
- Cost pressures were widespread: Material costs rose 17.2% QoQ, other expenses were up 29.5% YoY, and employee costs climbed 26.8% YoY, all contributing to the EBITDA per tonne falling 18.0% QoQ to ₹3,765.
Margin & Cost Structure
- EBITDA margin contracted sharply: The 388 bps QoQ decline to 13.6% reflected cost increases that outpaced revenue growth, with the YoY comparison also down 118 bps.
- Working capital quality is mixed: The subsidy-receivable reduction to ₹98 cr is a positive signal, but debtor days stretched from 74 in FY2023 to 83 in FY2024, while creditor days also lengthened from 8 to 41.
Capacity Expansion & Diversification
- A phased capacity build through FY27: Management detailed four major projects: a 33,000 MT phosphoric acid line in Madhya Pradesh (2QFY26), and three Maharashtra projects, a 99,000 MT phosphoric acid line, a 198,000 MT sulphuric acid line, and a 330,000 MT DAP/NPK line, all targeted for 3QFY27.
- Maharashtra plant relocation is the centerpiece: The Group has signed a definitive agreement to purchase a fertilizer plant with phosphoric acid and ammonia storage at Dahej, which will be relocated to Nardana, where site development is already in progress and commissioning is expected by October 2026.
- Land bank supports the ambition: The company has been allotted 137,052 sq mtrs adjacent to its existing Sagar plant and 587,350 sq mtrs by MIDC at Nardana, securing the physical footprint for the expansion.
- Geographic and product diversification in parallel: The Maharashtra facility expands the company beyond its Madhya Pradesh base into Maharashtra and Southern markets, while the phosphoric acid capacity is designed for both captive consumption and external sales to regional fertilizer companies.
- Backward integration remains the moat: MBAPL is India's only manufacturer with full backward integration, with access to adequate low-grade rock phosphate and beneficiation that management says ensures sustainable and efficient operations.
Balance Sheet & Cash Flow
- FY2024 delivered a cash-flow turnaround: Operating cash flow swung to positive ₹149.04 cr from negative ₹70.04 cr in FY2023, while total debt reduced from ₹322.55 cr to ₹289.62 cr and the debt-equity ratio improved from 0.98 to 0.83.
- Return ratios compressed year-on-year: ROCE fell from 45.31% in FY2023 to 18.47% in FY2024, and RONW declined from 37.82% to 7.08%, reflecting the capital deployed for the ongoing expansion cycle.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Phosphoric acid capacity (MP) | 33,000 MT, captive consumption | 2QFY26 |
| Maharashtra plant commissioning | Relocated Dahej plant at Nardana | October 2026 |
| DAP/NPK capacity (Maharashtra) | 330,000 MT | 3QFY27 |
| Phosphoric acid capacity (Maharashtra) | 99,000 MT, captive and external sales | 3QFY27 |
| Sulphuric acid capacity (Maharashtra) | 198,000 MT, captive consumption | 3QFY27 |
| Geographical diversification | Expand beyond Madhya Pradesh into Maharashtra and Southern markets | Target 2027 |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue from operations | ₹278.3 cr, up 38.9% QoQ, down 0.1% YoY |
| Total income | ₹280.0 cr, up 38.7% QoQ, up 0.3% YoY |
| EBITDA | ₹38.0 cr, up 7.9% QoQ, down 7.7% YoY |
| EBITDA margin | 13.6%, down 388 bps QoQ, down 118 bps YoY |
| EBITDA per tonne | ₹3,765, down 18.0% QoQ, down 13.1% YoY |
| PAT | ₹13.8 cr, up 20.5% QoQ, down 7.3% YoY |
| PAT margin | 5.0%, down 76 bps QoQ, down 39 bps YoY |
| Basic EPS | ₹1.58, up 20.5% QoQ, down 7.3% YoY |
| Finance cost | ₹6.6 cr, down 24.4% QoQ, down 19.8% YoY |
| Subsidy outstanding | ₹98 cr as of Sep 30, 2024, vs ₹115 cr as of Jun 30, 2024 |
| DAP sales volume | Nil in the quarter |
| Employee benefits expenses | ₹5.6 cr, up 26.8% YoY |
| Other expenses | ₹38.8 cr, up 29.5% YoY |
| H1 FY25 revenue | ₹478.7 cr, up 12.0% YoY |
| H1 FY25 EBITDA | ₹73.3 cr, up 10.4% YoY |
| H1 FY25 PAT | ₹25.3 cr, up 14.2% YoY |